Subretinal implant for retinitis pigmentosa
According to Dr. Eberhart Zrenner, MD, of the University of Tübingen in Germany, electronic subretinal implants provide hope for the restoration of some useful, functional vision in patients blinded by retinitis pigmentosa.
Dr. Zrenner discussed the 12-month visual and safety outcomes of a multi-center study of 1500-pixel subretinal implants at the 14th EURETINA Congress. These generate an 11x11 degree visual field to patients by stimulating the overlying bipolar cells.
The patients, whose average age was 53 years, had, on average, lost the ability to read 17 years ago. Of interest, detection, localization and recognition of shapes and objects in an ADL task was significantly better with implant power switched on than off during the first three months (p<0.05). Four patients (14%) could read letters 4-8 cm in size. Thirteen patients (45%) reported useful visual experiences, including recognition of shapes or details in daily life and 8 patients (28%) could localize objects in daily life.
Latest Articles
Addressing Postoperative Visual Complications
Managing aberrations after laser refractive surgery requires a multi-layered approach.
3D Printing Helps Transform Ukrainian Eye Care
The country’s ophthalmologists offer valuable experience in treating ocular trauma and prosthesis design.
Winning Essay Says ‘Collective Desire’ Must Drive DEI Implementation
Emerging Microbial Trends That Could Affect Your Practices
A triptych of challenges paints a concerning picture for ophthalmologists across the globe.
Improving Outcomes with Laser-Assisted Surgery
Femtosecond laser offers a multifunctional tool for improving the safety and efficacy of cataract and refractive lens exchange procedures.
Could the Corneal Transplant Pool Increase?
Modifying or discarding major contraindications for keratoplasty could mean more patients have their sight restored.
Matching Premium IOLs to Visual Lifestyles
From monofocal to full-range solutions, each practice needs comprehensive understanding.
Going Dutch on Acanthamoeba Keratitis
A world-first trial suggests a new medication could beat the disease.
Avoiding Intracorneal Ring Segment Complications
Femtosecond lasers are helping improve refractive results with fewer problems.